This study highlights the crosstalk between BAT and septic liver injury, and future research could focus on using BAT activation or Nrg4 as a therapeutic approach to mitigate liver injury in sepsis, providing valuable guidance for treating sepsis-related liver damage. This evidence concerns the gene NRG4 and Sepsis.